title: Clinical practice guidelines for hypertension in China: a systematic review of the methodological quality.
abstract: OBJECTIVE
  Clinical practice guidelines (CPGs) provide clinicians with specific recommendations for practice, but due to the increasing number of CPGs developed by diverse organisations over the past few years, there are concerns about the quality of some CPGs. This paper proposes a systematic review of the methodological quality of the CPGs for hypertension that were developed in China.
  
  
  METHODS
  A systematic review of CPGs for the management of hypertension in adult patients in China.
  
  
  METHODS
  Chinese electronic databases, Chinese guideline websites and Google Scholar were searched, and the reference lists of relevant publications were also screened for additional information. CPGs for the management of hypertension in adult patients were identified. The main characteristics of the CPGs were extracted, and the scaled Appraisal of Guidelines, REsearch and Evaluation II (AGREE II) domain percentages were independently evaluated by two reviewers.
  
  
  RESULTS
  A total of 17 CPGs, with publication dates ranging from 2001 to 2011, were identified. There was considerable variation in the quality of the CPGs across the AGREE II domains. Overall, the domains of 'rigor of development' and 'editorial independence' were poorly addressed, with an average score of 18% and 16%, respectively. Also less well addressed were the 'stakeholder involvement' and 'applicability' domains, for which the average domain scores were 28% and 20%, respectively. The CPGs performance was less problematic in the domains of 'scope and purpose' and 'clarity and presentation', with a median of 41% for both. After considering the domain scores, 8 CPGs could be recommended with modification for use.
  
  
  CONCLUSIONS
  There is considerable room for improvement of the methodological quality of CPGs for hypertension in China. Greater efforts should to be devoted to ensure the explicit and transparent reporting of potential conflicts of interest of stakeholders, and to consider the quality of the evidence and grade recommendations in the CPG development process.
authors.affiliation: Anhui Evidence-based Medicine Center, Anhui Provincial Hospital, Hefei, Anhui, China.
authors.forename: Yin
authors.initials: Y
authors.lastname: Chen
authors.affiliation: Anhui Evidence-based Medicine Center, Anhui Provincial Hospital, Hefei, Anhui, China Gerontology Institute of Anhui Province, Anhui Provincial Hospital, Hefei, Anhui, China.
authors.forename: Shilian
authors.initials: S
authors.lastname: Hu
authors.affiliation: Department of Neurology, Anhui Provincial Hospital, Hefei, Anhui, China.
authors.forename: Lei
authors.initials: L
authors.lastname: Wu
authors.affiliation: Department of Cardiology, Anhui Provincial Hospital, Hefei, Anhui, China.
authors.forename: Xiang
authors.initials: X
authors.lastname: Fang
authors.affiliation: Anhui Evidence-based Medicine Center, Anhui Provincial Hospital, Hefei, Anhui, China.
authors.forename: Weiping
authors.initials: W
authors.lastname: Xu
authors.affiliation: Anhui Evidence-based Medicine Center, Anhui Provincial Hospital, Hefei, Anhui, China.
authors.forename: Gan
authors.initials: G
authors.lastname: Shen
mesh_terms: D002681:China; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D017410:Practice Guidelines as Topic / Q000592:standards*